| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/13/2002 | EP1185522A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions containing them |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP0948455A4 Mixed peroxygen activator compositions |
| 03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
| 03/13/2002 | CN1339434A Process for extracting N-methyl morpholine and N-ethyl morpholine in morpholine waste water |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355801 Reacting n-(4-hydroxyphenyl)-piperazine with 1-halo-4-nitrobenzene in presence of organic base, reducing compound formed |
| 03/12/2002 | US6355800 Reacting 4-acyl-1-piperazinecarbamic acid with acid or its reactive derivative |
| 03/12/2002 | US6355796 Reacting beta-amino-beta-(perfluoroalkyl)acrylate compound with base and carbamoyl chloride compound to form urea compound, reacting urea compound with phosphorus pentahalide or oxalyl halide |
| 03/12/2002 | US6355678 Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355672 Bone disorders; central nervous system disorders |
| 03/12/2002 | US6355670 Skin disorders |
| 03/12/2002 | US6355633 Contraceptives |
| 03/12/2002 | US6355632 Naphthyl compounds, intermediates, compositions, and methods |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/07/2002 | WO2002018358A1 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide |
| 03/07/2002 | WO2002018334A2 Sodium channel modulators |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018318A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001085680A3 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 03/07/2002 | WO2001070684A3 Peptidomimetic ligands for cellular receptors and ion channels |
| 03/07/2002 | WO2001068645A3 N-cyanomethylcarboxamides and their use as protease inhibitors |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | WO2001046166A3 Partially saturated calcium channel blockers |
| 03/07/2002 | WO2001044160A3 Method for producing combinatorial amine libraries |
| 03/07/2002 | US20020028833 Aryl alkenamides derivatives as mcp-1 antagonists |
| 03/07/2002 | US20020028822 Medicament for treatment of diastolic dysfunction |
| 03/07/2002 | US20020028818 2-nitrostyryl-1-(naphthylmethyl)sulfone for example |
| 03/07/2002 | US20020028801 Analgesics, antiischemic agents, antieoileptic agents |
| 03/07/2002 | US20020028760 Nervous system disorders; hypotensive agents; incontinence |
| 03/07/2002 | DE10040783A1 AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) AZA-amino acid derivatives (factor inhibitors X¶a¶ 15) |
| 03/07/2002 | CA2420935A1 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide |
| 03/07/2002 | CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | CA2383855A1 Dyes for keratin fibers, the dyes containing n-benzyl-p-phenylenediamine derivatives and novel n-benzyl-p-phenylenediamine derivatives |
| 03/06/2002 | EP1183248A1 Non-linear optical devices and materials therefor |
| 03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183234A1 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183232A2 Monofluoroalkyl derivatives |
| 03/06/2002 | EP1183230A1 Valency platform molecules comprising aminooxy groups |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP1183074A1 Substituted biaryl ether compounds |
| 03/06/2002 | EP0883403A4 Method for treating sexual dysfunctions |
| 03/05/2002 | US6353136 Process for preparing aromatic amines in the presence of palladaphosphacyclobutane catalysts |
| 03/05/2002 | US6353118 Dewatering and purification of crude pyrrolidine |
| 03/05/2002 | US6353099 Substituted ureas as cell adhesion inhibitors |
| 03/05/2002 | US6353025 Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | CA2206122C Arylacrylamide derivatives |
| 02/28/2002 | WO2002016364A1 Polyethoxylated pyrazolo pyrimidinone derivatives, process for preparation thereof and pharmaceutical compositions comprising the same for the treatment of impotence |
| 02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
| 02/28/2002 | WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 02/28/2002 | WO2001056989A3 Inhibitors of factor xa |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | US20020025965 Antiserotonine agents |
| 02/28/2002 | US20020025920 Novel lipid complexes for transferring at least one therapeutically active substance, in particular a polynucleotide, into a target cell, and use in gene therapy |
| 02/28/2002 | CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/27/2002 | EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders |
| 02/27/2002 | EP1181267A1 Halogen compounds |
| 02/27/2002 | EP1181266A1 Squaric acid derivatives as cell adhesion molecules |
| 02/27/2002 | EP0915841B1 Anilinopeptide derivatives |
| 02/27/2002 | EP0825991B1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
| 02/27/2002 | CN1337956A New Morpholinobenzamide salts |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |
| 02/27/2002 | CN1079789C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
| 02/26/2002 | US6350916 Selective oxidation of alcohols to aldehydes or ketones |
| 02/26/2002 | US6350905 Catalytic reaction of olefin in the presence of osmium catalyst for aminohydroxylation |
| 02/26/2002 | US6350874 Method for producing triethylenediamines and piperazines |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2143249C Substituted sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
| 02/26/2002 | CA2111851C (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid |
| 02/21/2002 | WO2002014513A1 Use of polypeptide |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof |
| 02/21/2002 | WO2002014262A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2002 | WO2002013875A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 02/21/2002 | WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | US20020022647 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 02/21/2002 | US20020022643 1,1- and 1,2-disubstituted cyclopropane compounds |
| 02/21/2002 | US20020022630 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands |
| 02/21/2002 | US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 02/21/2002 | US20020022623 A substituted hydroxyethylene compound useful for treating Alzheimer's disease, mild cognitive impairment, Down's syndrome, herediatary cerebral hemmorrhage with amyloidosis, degenerative dementia |